🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Yong Wu

Beijing University of Posts and Telecommunications

ORCID: 0000-0002-1698-0897

Also affiliated with Nanchang University, Sun Yat-sen University, Guangxi Medical University, Nantong University, National Postdoctoral Association, Zhejiang Institute of Communications, Taizhou People's Hospital, State Key Laboratory of Food Science and Technology, Charles R. Drew University of Medicine and Science

Biochemistry, Genetics and Molecular BiologyEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile

0.204Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Survival Analysis and Prognostic Predictor Study of Colorectal Cancer Patients with Single-Site Metastasis

Clinical Oncology and Research(2021)10.31487/j.cor.2021.01.04

Top 65%

0.204DataRank

Top 65%2 citations

Wenhong Deng, Katrina M. Schrode, Magda Shaheen, Yong Wu, Jaydutt V. Vadgama

Papers

Driven by 14 papers — median percentile 35. Top paper: “Survival Analysis and Prognostic Predictor Study of Colorectal Cancer Patients with Single-Site Metastasis”.

Survival Analysis and Prognostic Predictor Study of Colorectal Cancer Patients with Single-Site Metastasis

Clinical Oncology and Research(2021)10.31487/j.cor.2021.01.04

Top 65%

0.204DataRank

Top 65%2 citations

Wenhong Deng, Katrina M. Schrode, Magda Shaheen, Yong Wu, Jaydutt V. Vadgama

Comp34 displays potent preclinical antitumor efficacy in triple-negative breast cancer via inhibition of NUDT3-AS4, a novel oncogenic long noncoding RNA

Cell Death and Disease(2020)10.1038/s41419-020-03235-w

N/A

0DataRank · unranked

20 citations

Piwen Wang, Pranabananda Dutta, Seyung Chung, Qun Li, Kun Wang +14 more

Basal-like breast cancer with low TGFβ and high TNFα pathway activity is rich in activated memory CD4 T cells and has a good prognosis

International Journal of Biological Sciences(2021)10.7150/ijbs.56128

N/A

0DataRank · unranked

28 citations

Jaydutt V. Vadgama, Yong Wu, Dingxie Liu

Tumor-Derived Exosomes in Tumor-Induced Immune Suppression

International Journal of Molecular Sciences(2022)10.3390/ijms23031461

N/A

0DataRank · unranked

75 citations

Yong Wu, Yanyuan Wu, Piwen Wang, Jaydutt V. Vadgama, Qiongyu Hao

Diaporine Potentiates the Anticancer Effects of Oxaliplatin and Doxorubicin on Liver Cancer Cells

Journal of Personalized Medicine(2022)10.3390/jpm12081318

N/A

0DataRank · unranked

5 citations

Rui Su, Ke Wu, Xuhan Zhou, Jaydutt V. Vadgama, Yong Wu +1 more

Advancements in small molecule drug design: A structural perspective

Drug Discovery Today(2023)10.1016/j.drudis.2023.103730

N/A

0DataRank · unranked

97 citations

Eduard Karapetyan, John V. Schloss, Jaydutt V. Vadgama, Yong Wu, Ke Wu

From Interaction to Intervention: How Mesenchymal Stem Cells Affect and Target Triple-Negative Breast Cancer

Biomedicines(2023)10.3390/biomedicines11041182

N/A

0DataRank · unranked

13 citations

Hang Chee Erin Shum, Ke Wu, Jaydutt V. Vadgama, Yong Wu

Potential Therapies Targeting the Metabolic Reprogramming of Diabetes-Associated Breast Cancer

Journal of Personalized Medicine(2023)10.3390/jpm13010157

N/A

0DataRank · unranked

9 citations

Ke Wu, Jaydutt V. Vadgama, Yong Wu, Hang Chee Erin Shum

Regulome‐wide association study identifies genetically driven accessible regions associated with pancreatic cancer risk

International Journal of Cancer(2023)10.1002/ijc.34761

N/A

0DataRank · unranked

3 citations

Hua Zhong, Jingjing Zhu, Yong Wu, Youping Deng, Lang Wu +1 more

Advancing Cancer Research: Insights and Innovations in Pathogenesis and Targeted Therapies

Journal of Personalized Medicine(2023)10.3390/jpm13030375

N/A

0DataRank · unranked

0 citations

Jaydutt V. Vadgama, Yong Wu

Proteome-wide association study and functional validation identify novel protein markers for pancreatic ductal adenocarcinoma

GigaScience(2024)10.1093/gigascience/giae012

N/A

0DataRank · unranked

7 citations

Ke Wu, Shuai Liu, Alexandra Masca, Hua Zhong, Tai Yang +15 more

Wip1 phosphatase activator QGC-8–52 specifically sensitizes p53-negative cancer cells to chemotherapy while protecting normal cells

Drug Resistance Updates(2024)10.1016/j.drup.2024.101196

N/A

0DataRank · unranked

6 citations

Xiaoxiao Ge, Xiao-xiao Ge, Jieqing Li, Kun Wang, Qiao‐Hong Chen +5 more

Palmitic acid negatively regulates tumor suppressor PTEN through T366 phosphorylation and protein degradation

Cancer Letters(2020)10.1016/j.canlet.2020.10.007

N/A

0DataRank · unranked

40 citations

Yong Wu, Poonamjot Deol, Yumiko Nobumori, Qi Zhou, Frances M. Sladek +2 more

Linking DNA methylation in brain regions to Alzheimer’s disease risk: a Mendelian randomization study

Human Molecular Genetics(2025)10.1093/hmg/ddaf053

N/A

0DataRank · unranked

3 citations

Jingjing Zhu, Shuai Liu, Dan Zhou, Quan Long, Chong Wu +13 more